|
Burrill & Co LLC |
Diversified global financial services firm focused on the life sciences industry |
United States |
+1 (415) 591-5400 |
Series B |
|
|
|
|
Burrill & Co LLC |
Diversified global financial services firm focused on the life sciences industry |
United States |
+1 (415) 591-5400 |
Series A |
|
|
|
|
Burrill & Co LLC |
Diversified global financial services firm focused on the life sciences industry |
United States |
+1 (415) 591-5400 |
Series C |
|
|
|
Essex Woodlands Health Ventures Inc |
|
United States |
+1 (281) 364-1555 |
Series C |
|
|
|
Healthcare Ventures LLC |
Venture capital firm focused on life sciences companies in pre-clinical and early clinical stage. |
United States |
+1 (617) 252-4343 |
Series C |
|
|
|
|
Healthcare Ventures LLC |
Venture capital firm focused on life sciences companies in pre-clinical and early clinical stage. |
United States |
+1 (617) 252-4343 |
Series B |
|
|
|
Johnson & Johnson Innovation LLC (JJDC Inc), (Johnson & Johnson Development Corp Inc) |
Accelerator of early-stage innovation worldwide that forms collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. |
United States |
+1 (732) 524-3218 |
Series C |
|
|
|
Morgenthaler Management Partners (Morgenthaler Ventures), (Morgenthaler Partners) |
One of the oldest private equity investment firms in the US investing through both venture capital and leverage buyout transactions. |
United States |
+1 (650) 388-7600 |
Series C |
|
|
|
|
Morgenthaler Management Partners (Morgenthaler Ventures), (Morgenthaler Partners) |
One of the oldest private equity investment firms in the US investing through both venture capital and leverage buyout transactions. |
United States |
+1 (650) 388-7600 |
Series B |
|
|
|
Novartis Services Inc (Novartis Venture Fund) |
|
United States |
+1 (617) 871-3536 |
N/A |
|
|
|
|
Novartis Services Inc (Novartis Venture Fund) |
|
United States |
+41 (61) 324-3714 |
N/A |
|
|
|
Novartis Venture Funds |
The corporate venturing arm of Novartis. |
Switzerland |
+41 (61) 324-6210 |
Series B |
|
|
|
|
Novartis Venture Funds |
The corporate venturing arm of Novartis. |
Switzerland |
+41 (61) 324-6210 |
Series C |
|
|
|
|
Novartis Venture Funds |
The corporate venturing arm of Novartis. |
Switzerland |
+41 (61) 324-6210 |
Series A |
|
|
|
RCT BioVentures (Research Corporation Technologies BioVentures) |
The vehicle through which Research Corporation Technologies invests in start-up or early-stage companies |
United States |
+1 (310) 824-1700 |
Series B |
|
|
|
|
RCT BioVentures (Research Corporation Technologies BioVentures) |
The vehicle through which Research Corporation Technologies invests in start-up or early-stage companies |
United States |
+1 (310) 824-1700 |
Series A |
|
|
|
Sofinnova Ventures Inc |
|
United States |
+1 (415) 228-3380 |
Series B |
|
|
|
|
Sofinnova Ventures Inc |
|
United States |
+1 (415) 228-3380 |
Series C |
|
|
|
|
Sofinnova Ventures Inc |
|
United States |
+1 (415) 228-3380 |
Series A |
|
|